MedPath

Multiplexing Prism Fitting for Field Expansion of Monocular Vision

Not Applicable
Completed
Conditions
Blind Left Eye
Blind Right Eye
One Eye Blindness
Interventions
Device: Multiplexing Prism
Registration Number
NCT06027216
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators are testing a simplified design and fitting protocol to provide field expansion for individuals with acquired monocular vision.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • No medical health issues such as seizures, motor movements problem
  • Loss of vision in one eye (less than 20/200) for >1 year)
  • Visual acuity of the seeing eye: Better than 20/32 visual acuity with correction
  • No visual field defect in the seeing eye (nasal field of at least >45degree)
  • No medical health issues such as seizures, motor movements problem
Exclusion Criteria
  • Patients with any physical or mental disabilities, including cognitive dysfunction, balance problems, or other deficits that could impair their ability to respond to the stimuli presented in this study will be excluded
  • Any person with motor movements problem (e.g., unable to use extremities)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Field ExpansionMultiplexing PrismField of view on the nasal side (same side as the blind eye) with and without multiplexing prism
Primary Outcome Measures
NameTimeMethod
Gain in Visual Field With the Multiplexing PrismVisit 2 of Study (approximately 2-3 weeks after 1st Visit)

Field expansion is calculated based on the difference of the maximum field of view on the nasal side of the seeing/functioning eye (same side as the blind eye) with and without multiplexing prism.

Secondary Outcome Measures
NameTimeMethod
Maximum Extent of Nasal Visual Field With the Multiplexing PrismVisit 2 of Study (approximately 2-3 weeks after 1st Visit)

The farthest extent of the nasal visual field with the multiplexing prism placed in front of the seeing eye.

Trial Locations

Locations (1)

Schepens Eye Research Institute

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath